<DOC>
	<DOC>NCT02202941</DOC>
	<brief_summary>This clinical trial is aimed to show a procalcitonin-guided treatment algorithm may shorten duration of antibiotic therapy safely and cost-effectively in sepsis patients of Korean ICU.</brief_summary>
	<brief_title>Procalcitonin-guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>All patients with suspicious or confirmed sepsis at admission or during stay in ICU Patients with antibiotic duration of less than 48 hours before enrollment Age less than or equal to 18 years Known pregnancy Specific infections for which longterm antibiotic treatment for 3 weeks more is strongly recommended: infective endocarditis, empyema, osteomyelitis et al. severe immunocompromised patients : HIV infected patients (CD4 count &lt; 200 cells/mm3), Neutropenia (ANC count &lt; 500/mm3) Presence of donotresuscitate order</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>